2018
DOI: 10.14218/jcth.2018.00002
|View full text |Cite
|
Sign up to set email alerts
|

Effect of Genistein in Comparison with Trichostatin A on Reactivation of DNMTs Genes in Hepatocellular Carcinoma

Abstract: Background and Aims: DNA methylation and histone modification are epigenetic modifications essential for normal function of mammalian cells. The processes are mediated by biochemical interactions between DNA methyltransferases (DNMTs) and histone deacetylases. Promoter hypermethylation and deacetylation of tumor suppressor genes play major roles in cancer induction, through transcriptional silencing of these genes. DNA hypermethylation is carried out by a family of DNMTs including DNMT1, DNMT3a and DNMT3b. In … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
23
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
6
3

Relationship

2
7

Authors

Journals

citations
Cited by 36 publications
(23 citation statements)
references
References 46 publications
0
23
0
Order By: Relevance
“…Trichostatin A induces hyperacetylation of the core histone followed by structural modulation of chromatin, and finally causes the promotion of selective gene transcription and the suppression of tumor growth by reversibly inhibiting deacetylases. Currently, trichostatin A has been used in the treatment of laryngeal cancer and as a novel biomarker for nasopharyngeal carcinoma, and is also used to prevent the side effects of cisplatin in the treatment of cancer ( 38 ). It may have positive effects on CCA treatment.…”
Section: Discussionmentioning
confidence: 99%
“…Trichostatin A induces hyperacetylation of the core histone followed by structural modulation of chromatin, and finally causes the promotion of selective gene transcription and the suppression of tumor growth by reversibly inhibiting deacetylases. Currently, trichostatin A has been used in the treatment of laryngeal cancer and as a novel biomarker for nasopharyngeal carcinoma, and is also used to prevent the side effects of cisplatin in the treatment of cancer ( 38 ). It may have positive effects on CCA treatment.…”
Section: Discussionmentioning
confidence: 99%
“…Previously, we reported the effect of DNMT inhibitors 5-Aza-CdR and GE in HCC. [ 12 13 ] In the present study, we report that 5-Aza-CdR can inhibit PLC/PRF cell and induce apoptosis by epigenetic reactivation of p15INK4, p16INK4, p18INK4, and p19INK4 genes. Similarly, a regulatory link has been reported between DNMT downregulation and cell cycle regulator p21 WAF1 protein upregulation.…”
Section: Discussionmentioning
confidence: 57%
“…[ 11 ] Previously, we reported the effect of DNA demethylating agent 5-Aza-CdR and genistein (GE) on DNMTs in HCC. [ 12 13 ] The aim of the present study was to evaluate the effect of 5-Aza-CdR on p15INK4, p16INK4, p18INK4, and p19INK4 genes expression, cell growth inhibition, and apoptosis induction in HCC PLC/PRF/5 cell line.…”
Section: Introductionmentioning
confidence: 99%
“…DNA hypermethylation is carried out by a family of DNMTs including DNMT3A. In hepatocellular carcinoma, a positive correlation between the overexpression of these genes and cancer induction has been reported to be significant (41). DNMT3A protein expression was depleted in AGS cells treated with SCU, and functional analysis indicated its role in the apoptotic process by GO.…”
Section: Discussionmentioning
confidence: 99%